Evidence map›Paper›PMID 40956369›Full record

ArticleJournal of cancer research and clinical oncology2025

Correction: Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review.

Roberto Rosenfeld, Stefano Sganga, Marco Badalamenti, Sveva Mortellaro, Marta Scorsetti, Ornella Garrone, Giovanni Maria Iannantuono, Elias Chandran, Michele Ghidini, Ciro Franzese

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Roberto RosenfeldPrecision Medicine in Senology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Stefano SgangaComprehensive Cancer Center, Medical Oncology Department, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, IT, Faculty of Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
Marco BadalamentiDepartment of Radiotherapy and Radiosurgery, Humanitas Research Center-IRCCS, Rozzano, Milan, Italy.
Sveva MortellaroPostgraduate School in Radiodiagnostics, Università Degli Studi Di Milano, Milan, Italy.
Marta ScorsettiDepartment of Radiotherapy and Radiosurgery, Humanitas Research Center-IRCCS, Rozzano, Milan, Italy.
Ornella GarroneOncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Sforza 28, 20122, Milan, Italy.
Giovanni Maria IannantuonoPhase 1 Unit, Fondazione Policlinico Universitario A. Gemelli, Istituto Di Ricovero E Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Elias ChandranGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Michele GhidiniOncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Sforza 28, 20122, Milan, Italy. michele.ghidini@policlinico.mi.it.
Ciro FranzeseDepartment of Radiotherapy and Radiosurgery, Humanitas Research Center-IRCCS, Rozzano, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40956369
PMCPMC12440834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.